Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.

NCT00225264 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

458

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Pioglitazone
DRUG: Glimepiride

Sponsor

Takeda